VAISHALI — Vaishali Pharma Share Price
0.000.00%
Last trade - 00:00- IN₹1.69bn
- IN₹1.51bn
- IN₹990.26m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.11 | ||
| Price to Tang. Book | 2.14 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.44 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -1.63% | ||
| Return on Equity | 0.76% | ||
| Operating Margin | -1.16% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 600.86 | 537.74 | 758.21 | 696.63 | 862.8 | n/a | n/a | 2.82% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -95.4 | +3090.03 | +284.57 | +54.92 | -88.54 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Vaishali Pharma Limited is an India-based pharmaceutical company. The Company is in the pharmaceutical business, mainly dealing in active pharmaceutical ingredients, pharmaceutical formulations, surgical products, and veterinary supplements, operating in domestic and export markets. Its product categories include active pharmaceutical ingredients (APIs), formulation brands, formulations, herbal, nutraceutical, oncology, surgical, and veterinary. The Company has manufactured and exported approximately 250 formulations and specializes in manufacturing tailor-made formulations. It offers APIs, including antibiotics, anti-ulcer, anti-inflammatory/analgesic/ anti-pyretic, anti-malarial, cardiac, anti-diabetic, anti-cold/anti-allergic, antiviral, antifungal, skeletal muscle relaxant, and anthelmintic drugs, excipients, topical steroids, corticosteroids, and enzymes. It has a global presence in Asia & Pacific, Africa, the Commonwealth of Independent States, America, and the Middle East.
Directors
- Atul Vasani CHM (52)
- Hemanth Pathak CEO
- Ratnesh Singh CFO (39)
- Akshay Jharkhandi CCO
- Jagruti Vasani EDR (54)
- Dewansh Vasani NED (25)
- Ashvin Ganatra NID (51)
- Prataprai Gandhi NID (78)
- Manish Ved NID (54)
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- April 25th, 2008
- Public Since
- August 22nd, 2017
- No. of Shareholders
- 9,508
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 107,192,130
- Address
- 706-709, Aravalli Business Center R.C.Pa, MUMBAI, 400092
- Web
- https://www.vaishalipharma.com/
- Phone
- +91 2242171819
- Auditors
- Raman S Shah & Associates
Upcoming Events for VAISHALI
Q1 2026 Vaishali Pharma Ltd Earnings Release
Vaishali Pharma Ltd Annual Shareholders Meeting
Q2 2026 Vaishali Pharma Ltd Earnings Release
Similar to VAISHALI
Aarey Drugs and Pharmaceuticals
National Stock Exchange of India
Aarti Drugs
National Stock Exchange of India
Aarti Pharmalabs
National Stock Exchange of India
Abbott India
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
FAQ
What is the Vaishali Pharma share price?
As of Today at 23:53 UTC, shares in Vaishali Pharma are trading at IN₹13.34. This share price information is delayed by 15 minutes.
How has the Vaishali Pharma share price performed this year?
Shares in Vaishali Pharma last closed at IN₹13.34 and the price had moved by -15.73% over the past 365 days. In terms of relative price strength the Vaishali Pharma share price has underperformed the S&P BSE 100 Index by -23.08% over the past year.
What are the analyst and broker recommendations for Vaishali Pharma?
There is no consensus recommendation for this security.
Find out moreWhat is the Vaishali Pharma dividend yield?
Vaishali Pharma does not currently pay a dividend.
Does Vaishali Pharma pay a dividend?
Vaishali Pharma does not currently pay a dividend.
When does Vaishali Pharma next pay dividends?
Vaishali Pharma does not currently pay a dividend.
How do I buy Vaishali Pharma shares?
To buy shares in Vaishali Pharma you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Vaishali Pharma?
As of the previous close price of IN₹13.34, shares in Vaishali Pharma had a market capitalisation of IN₹1.43bn.
Where are Vaishali Pharma shares listed?
Here are the trading details for Vaishali Pharma:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: VAISHALI
What kind of share is Vaishali Pharma?
Based on an overall assessment of its quality, value and momentum Vaishali Pharma is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Vaishali Pharma share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Vaishali Pharma share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Vaishali Pharma. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -24.02%.
As of the last closing price of IN₹13.34, shares in Vaishali Pharma were trading -18.15% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Vaishali Pharma PE Ratio?
The Vaishali Pharma PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹13.34.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Vaishali Pharma?
Vaishali Pharma's management team is headed by:
- Atul Vasani - CHM
- Hemanth Pathak - CEO
- Ratnesh Singh - CFO
- Akshay Jharkhandi - CCO
- Jagruti Vasani - EDR
- Dewansh Vasani - NED
- Ashvin Ganatra - NID
- Prataprai Gandhi - NID
- Manish Ved - NID